تولید مواد اولیه داروپخش
دتماد | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 58,820 2.99
Close Price: 58,180
Income Statement
AGM
Interim
2026/07/07 Fiscal Year 2026/03/2012 Month | 2025/05/18 Fiscal Year 2025/03/2012 Month | 2024/05/16 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 31.201 Trillion | 21.926 Trillion | 19.223 Trillion | |
Total Revenues | 31.201 Trillion | 21.926 Trillion | 19.223 Trillion | |
Cost of Goods Sold | 16.244 Trillion | 12.64 Trillion | 10.629 Trillion | |
Gross Profit | 14.957 Trillion | 9.286 Trillion | 8.595 Trillion | |
General & Administrative Expenses | 1.412 Trillion | 1.448 Trillion | 982.029 Billion | |
Net Operating Income & Expenses | 2.209 Trillion | 1.05 Trillion | 384.024 Billion | |
Operating Profit (Loss) | 15.753 Trillion | 8.888 Trillion | 7.997 Trillion | |
Profit Before Tax | 14.879 Trillion | 8.23 Trillion | 7.308 Trillion | |
Tax | 2.425 Trillion | 1.541 Trillion | 1.283 Trillion | |
Net Profit (Loss) After Tax | 12.454 Trillion | 6.689 Trillion | 6.026 Trillion | |
Retained Earnings at Beginning of Period | 8.937 Trillion | 6.537 Trillion | 5.121 Trillion | |
Approved Dividends — Prior Year AGM | -5.506 Trillion | -4.29 Trillion | -4.609 Trillion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | -2.085 Trillion | - | - | |
Allocable Profit | 13.8 Trillion | 8.937 Trillion | 6.537 Trillion | |
Legal Reserve | 208.5 Billion | - | - | |
Approved Dividends — Current Year | 7.7 Trillion | 5.506 Trillion | 4.29 Trillion | |
Retained Earnings at End of Period | 5.892 Trillion | 3.431 Trillion | 2.247 Trillion |